SARS-CoV-2 Proficiency Testing Scheme
EPTIS factsheet 769005 | Last revision 2022-05-04 | URL: https://www.eptis.bam.de/pts769005 https://www.eptis.bam.de/pts769005
| PT provider | |||||||||||||||||||||||||||||||
| PT provider | LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing | ||||||||||||||||||||||||||||||
| Based in | United Kingdom | ||||||||||||||||||||||||||||||
| Language(s) | |||||||||||||||||||||||||||||||
| Remarks | The primary aim of the Clinical Laboratory proficiency testing scheme (CLS) is to enable laboratories performing analysis of clinical samples to monitor their performance and compare it with that of their peers. The CLS scheme also aims to provide information to participants on technical issues and methodologies relating to Clinical Laboratory Science. The CLS scheme year operates from January to December. Further information about CLS, including test material availability, round despatch dates and reporting deadlines, are available on the current CLS application form. The operation of the scheme is supported by an Advisory Group consisting of experts in the field of Clinical Laboratory Science and proficiency testing. The scheme reports on the performance of U.K. participants to the National Quality Assurance Advisory Panels for Chemical Pathology and for Medical Microbiology. | ||||||||||||||||||||||||||||||
| Keywords | |||||||||||||||||||||||||||||||
| Product groups |
Human test material
|
||||||||||||||||||||||||||||||
| Testing fields |
Biology
Medical analysis Microbiology |
||||||||||||||||||||||||||||||
| Technical details | |||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
| Aims of the PT scheme | |||||||||||||||||||||||||||||||
| Target group of participants | Clinical laboratories, other | ||||||||||||||||||||||||||||||
| Linked to specific legislation / standards | |||||||||||||||||||||||||||||||
| Additional, subsidiary aims | validation of testing methods | ||||||||||||||||||||||||||||||
| Number of participants | |||||||||||||||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by A2LA, UKAS, ILAV-MRA on the basis of ISO/IEC 17043:2010 for part of the parameters |
||||||||||||||||||||||||||||||
| Operation is commissioned / requested by | |||||||||||||||||||||||||||||||
| Fees and frequency | |||||||||||||||||||||||||||||||
| Participation fee | Fees vary according to selection from available groups. | ||||||||||||||||||||||||||||||
| Regularly operated | Yes (12 rounds per year) | ||||||||||||||||||||||||||||||
| Year of first operation | 2018 | ||||||||||||||||||||||||||||||
| Contact details of the PT provider | |||||||||||||||||||||||||||||||
| Provider | Contact person | ||||||||||||||||||||||||||||||
|
LGC AXIO Proficiency Testing
1 Chamberhall Business Park, Chamberhall Green BL9 0AP Bury, Greater Manchester United Kingdom Phone: +44 (0)161 762 2500 Fax: +44 (0)161 762 2501 Web: https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597 https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597 |
Mrs Nicola Armstrong
Phone: +44 (0)161 762 2500 Fax: Email: axiopt@lgcgroup.com axiopt@lgcgroup.com |
||||||||||||||||||||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.